The two most common histological subtypes of malignant germ cell tumour are distinguished by global microRNA profiles, associated with differential transcription factor expression

Molecular Cancer

Volumn 9, Issue , 2010, Pages

  Murray, Matthew J ^a   Saini, Harpreet K ^b   van Dongen, Stijn ^b   Palmer, Roger D ^a   Muralidhar, Balaji ^a   Pett, Mark R ^a   Piipari, Matias ^c   Thornton, Claire M ^d   Nicholson, James C ^e   Enright, Anton J ^b   Coleman, Nicholas ^a,f  

^a MEDICAL RESEARCH COUNCIL   (United Kingdom)

^b EUROPEAN BIOINFORMATICS INSTITUTE   (United Kingdom)

^c WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^d ROYAL GROUP OF HOSPITALS TRUST   (United Kingdom)

^e ADDENBROOKE S HOSPITAL   (United Kingdom)

^f UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 122; MICRORNA 200B; MICRORNA 205; MICRORNA 302; MICRORNA 302B; MICRORNA 375; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR 7 LIKE 2; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR GATA 6; TRANSCRIPTION FACTOR MAF; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; DOWN REGULATION; GERM CELL TUMOR; HUMAN; HUMAN TISSUE; PROTEIN EXPRESSION; PROTEIN MOTIF; REAL TIME POLYMERASE CHAIN REACTION; RNA BINDING; RNA SEQUENCE; ADOLESCENT; ADULT; CHILD; DNA MICROARRAY; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; INFANT; MALE; NEOPLASM; PRESCHOOL CHILD; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INFANT; MALE; MICRORNAS; NEOPLASMS, GERM CELL AND EMBRYONAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION FACTORS; YOUNG ADULT;

EID: 78049473522     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-9-290     Document Type: Article

References (44)

1. Murray MJ, Nicholson JC. Germ Cell Tumours in Children and Adolescents. Paediatrics and Child Health 2010, 20:109-116.
2. Bamberg M, Kortmann RD, Calaminus G, Becker G, Meisner C, Harms D, Gobel U. Radiation therapy for intracranial germinoma: results of the German cooperative prospective trials MAKEI 83/86/89. J Clin Oncol 1999, 17:2585-2592.
3. Hoffman HJ, Otsubo H, Hendrick EB, Humphreys RP, Drake JM, Becker LE, Greenberg M, Jenkin D. Intracranial germ-cell tumors in children. J Neurosurg 1991, 74:545-551. 10.3171/jns.1991.74.4.0545, 1848284.
4. Calaminus G, Bamberg M, Harms D, Jurgens H, Kortmann RD, Sorensen N, Wiestler OD, Gobel U. AFP/beta-HCG secreting CNS germ cell tumors: long-term outcome with respect to initial symptoms and primary tumor resection. Results of the cooperative trial MAKEI 89. Neuropediatrics 2005, 36:71-77. 10.1055/s-2005-837582, 15822019.
5. International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group. J Clin Oncol 1997, 15:594-603.
6. Baranzelli MC, Kramar A, Bouffet E, Quintana E, Rubie H, Edan C, Patte C. Prognostic factors in children with localized malignant nonseminomatous germ cell tumors. J Clin Oncol 1999, 17:1212.
7. Palmer RD, Barbosa-Morais NL, Gooding EL, Muralidhar B, Thornton CM, Pett MR, Roberts I, Schneider DT, Thorne N, Tavare S, et al. Pediatric malignant germ cell tumors show characteristic transcriptome profiles. Cancer Res 2008, 68:4239-4247. 10.1158/0008-5472.CAN-07-5560, 18519683.
8. Palmer RD, Murray MJ, Saini HK, van Dongen S, Abreu-Goodger C, Muralidhar B, Pett MR, Thornton CM, Nicholson JC, Enright AJ, Coleman N. Malignant Germ Cell Tumors Display Common microRNA Profiles Resulting in Global Changes in Expression of Messenger RNA Targets. Cancer Research 2010, 70:2911-2923. 10.1158/0008-5472.CAN-09-3301, 20332240.
9. Gillis AJ, Stoop HJ, Hersmus R, Oosterhuis JW, Sun Y, Chen C, Guenther S, Sherlock J, Veltman I, Baeten J, et al. High-throughput microRNAome analysis in human germ cell tumours. J Pathol 2007, 213:319-328. 10.1002/path.2230, 17893849.
10. Korkola JE, Houldsworth J, Chadalavada RS, Olshen AB, Dobrzynski D, Reuter VE, Bosl GJ, Chaganti RS. Down-regulation of stem cell genes, including those in a 200-kb gene cluster at 12p13.31, is associated with in vivo differentiation of human male germ cell tumors. Cancer Res 2006, 66:820-827. 10.1158/0008-5472.CAN-05-2445, 16424014.
11. Down TA, Bergman CM, Su J, Hubbard TJ. Large-scale discovery of promoter motifs in Drosophila melanogaster. PLoS Comput Biol 2007, 3:e7. 10.1371/journal.pcbi.0030007, 1779301, 17238282.
12. Piipari M, Down TA, Saini H, Enright A, Hubbard TJ. iMotifs: an integrated sequence motif visualization and analysis environment. Bioinformatics 2010, 26:843-844. 10.1093/bioinformatics/btq026, 2832821, 20106815.
13. Benjamini YHY. Controlling the false discovery rate - a practical and powerful approach to multiple testing. J R Stat Soc Ser B-Methodol 1995, 57:289-300.
14. Muralidhar B, Goldstein LD, Ng G, Winder DM, Palmer RD, Gooding EL, Barbosa-Morais NL, Mukherjee G, Thorne NP, Roberts I, et al. Global microRNA profiles in cervical squamous cell carcinoma depend on Drosha expression levels. J Pathol 2007, 212:368-377. 10.1002/path.2179, 17471471.
15. Ruxton GD. The unequal variance t-test is an underused alternative to Student's t-test and the Mann-Whitney U test. Behavioral Ecology 2006, 17:688-690.
16. Lagos-Quintana M, Rauhut R, Lendeckel W, Tuschl T. Identification of novel genes coding for small expressed RNAs. Science 2001, 294:853-858. 10.1126/science.1064921, 11679670.
17. Lau NC, Lim LP, Weinstein EG, Bartel DP. An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans. Science 2001, 294:858-862. 10.1126/science.1065062, 11679671.
18. Flicek P, Aken BL, Ballester B, Beal K, Bragin E, Brent S, Chen Y, Clapham P, Coates G, Fairley S, et al. Ensembl's 10th year. Nucleic Acids Res 2010, 38:D557-562. 10.1093/nar/gkp972, 2808936, 19906699.
19. Morgulis A, Gertz EM, Schaffer AA, Agarwala R. WindowMasker: window-based masker for sequenced genomes. Bioinformatics 2006, 22:134-141. 10.1093/bioinformatics/bti774, 16287941.
20. Matys V, Kel-Margoulis OV, Fricke E, Liebich I, Land S, Barre-Dirrie A, Reuter I, Chekmenev D, Krull M, Hornischer K, et al. TRANSFAC and its module TRANSCompel: transcriptional gene regulation in eukaryotes. Nucleic Acids Res 2006, 34:D108-110. 10.1093/nar/gkj143, 1347505, 16381825.
21. Marson A, Levine SS, Cole MF, Frampton GM, Brambrink T, Johnstone S, Guenther MG, Johnston WK, Wernig M, Newman J, et al. Connecting microRNA genes to the core transcriptional regulatory circuitry of embryonic stem cells. Cell 2008, 134:521-533. 10.1016/j.cell.2008.07.020, 2586071, 18692474.
22. Lim LP, Lau NC, Garrett-Engele P, Grimson A, Schelter JM, Castle J, Bartel DP, Linsley PS, Johnson JM. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 2005, 433:769-773. 10.1038/nature03315, 15685193.
23. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA, et al. MicroRNA expression profiles classify human cancers. Nature 2005, 435:834-838. 10.1038/nature03702, 15944708.
24. Peter ME. Let-7 and miR-200 microRNAs: guardians against pluripotency and cancer progression. Cell Cycle 2009, 8:843-852. 2688687, 19221491.
25. Gregory PA, Bert AG, Paterson EL, Barry SC, Tsykin A, Farshid G, Vadas MA, Khew-Goodall Y, Goodall GJ. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 2008, 10:593-601. 10.1038/ncb1722, 18376396.
26. Gee GV, Koestler DC, Christensen BC, Sugarbaker DJ, Ugolini D, Ivaldi GP, Resnick MB, Houseman EA, Kelsey KT, Marsit CJ. Downregulated MicroRNAs in the differential diagnosis of malignant pleural mesothelioma. Int J Cancer 2010,
27. Gregory PA, Bracken CP, Bert AG, Goodall GJ. MicroRNAs as regulators of epithelial-mesenchymal transition. Cell Cycle 2008, 7:3112-3118.
28. Korpal M, Kang Y. The emerging role of miR-200 family of microRNAs in epithelial-mesenchymal transition and cancer metastasis. RNA Biol 2008, 5:115-119.
29. Olson P, Lu J, Zhang H, Shai A, Chun MG, Wang Y, Libutti SK, Nakakura EK, Golub TR, Hanahan D. MicroRNA dynamics in the stages of tumorigenesis correlate with hallmark capabilities of cancer. Genes Dev 2009, 23:2152-2165. 10.1101/gad.1820109, 2751988, 19759263.
30. Looijenga LH. Human testicular (non)seminomatous germ cell tumours: the clinical implications of recent pathobiological insights. J Pathol 2009, 218:146-162. 10.1002/path.2522, 19253916.
31. Wang HW, Wu YH, Hsieh JY, Liang ML, Chao ME, Liu DJ, Hsu MT, Wong TT. Pediatric primary central nervous system germ cell tumors of different prognosis groups show characteristic miRNome traits and chromosome copy number variations. BMC Genomics 2010, 11:132. 10.1186/1471-2164-11-132, 2837036, 20178649.
32. Zovoilis A, Nolte J, Drusenheimer N, Zechner U, Hada H, Guan K, Hasenfuss G, Nayernia K, Engel W. Multipotent adult germline stem cells and embryonic stem cells have similar microRNA profiles. Mol Hum Reprod 2008, 14:521-529. 10.1093/molehr/gan044, 18697907.
33. Suh MR, Lee Y, Kim JY, Kim SK, Moon SH, Lee JY, Cha KY, Chung HM, Yoon HS, Moon SY, et al. Human embryonic stem cells express a unique set of microRNAs. Dev Biol 2004, 270:488-498. 10.1016/j.ydbio.2004.02.019, 15183728.
34. Barroso-delJesus A, Romero-Lopez C, Lucena-Aguilar G, Melen GJ, Sanchez L, Ligero G, Berzal-Herranz A, Menendez P. Embryonic stem cell-specific miR302-367 cluster: human gene structure and functional characterization of its core promoter. Mol Cell Biol 2008, 28:6609-6619. 10.1128/MCB.00398-08, 2573233, 18725401.
35. Stadler BM, Ivanovska I, Mehta K, Song S, Nelson A, Tan Y, Mathieu J, Darby GC, Blau CA, Ware C, et al. Characterization of microRNAs Involved in Embryonic Stem Cell States. Stem Cells Dev 2010, 19:935-950. 10.1089/scd.2009.0426, 20128659.
36. Blenkiron C, Goldstein LD, Thorne NP, Spiteri I, Chin SF, Dunning MJ, Barbosa-Morais NL, Teschendorff AE, Green AR, Ellis IO, et al. MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype. Genome Biol 2007, 8:R214. 10.1186/gb-2007-8-10-r214, 2246288, 17922911.
37. Card DA, Hebbar PB, Li L, Trotter KW, Komatsu Y, Mishina Y, Archer TK. Oct4/Sox2-regulated miR-302 targets cyclin D1 in human embryonic stem cells. Mol Cell Biol 2008, 28:6426-6438. 10.1128/MCB.00359-08, 2577422, 18710938.
38. Looijenga LH, Stoop H, de Leeuw HP, de Gouveia BC, Gillis AJ, van Roozendaal KE, van Zoelen EJ, Weber RF, Wolffenbuttel KP, van Dekken H, et al. POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors. Cancer Res 2003, 63:2244-2250.
39. Yuan Y, Guo L, Shen L, Liu JS. Predicting gene expression from sequence: a reexamination. PLoS Comput Biol 2007, 3:e243. 10.1371/journal.pcbi.0030243, 2098866, 18052544.
40. Kleinjan DA, van Heyningen V. Long-range control of gene expression: emerging mechanisms and disruption in disease. Am J Hum Genet 2005, 76:8-32. 10.1086/426833, 1196435, 15549674.
41. Cao D, Guo S, Allan RW, Molberg KH, Peng Y. SALL4 is a novel sensitive and specific marker of ovarian primitive germ cell tumors and is particularly useful in distinguishing yolk sac tumor from clear cell carcinoma. Am J Surg Pathol 2009, 33:894-904. 10.1097/PAS.0b013e318198177d, 19295406.
42. Cao D, Humphrey PA, Allan RW. SALL4 is a novel sensitive and specific marker for metastatic germ cell tumors, with particular utility in detection of metastatic yolk sac tumors. Cancer 2009, 115:2640-2651. 10.1002/cncr.24308, 19365862.
43. Cao D, Li J, Guo CC, Allan RW, Humphrey PA. SALL4 is a novel diagnostic marker for testicular germ cell tumors. Am J Surg Pathol 2009, 33:1065-1077. 10.1097/PAS.0b013e3181a13eef, 19390421.
44. Arvey A, Larsson E, Sander C, Leslie CS, Marks DS. Target mRNA abundance dilutes microRNA and siRNA activity. Mol Syst Biol 2010, 6:363. 10.1038/msb.2010.24, 2872614, 20404830.